Yoga for Symptoms of Nerve Damage Caused by Chemotherapy
| Status: | Recruiting |
|---|---|
| Conditions: | Breast Cancer, Cervical Cancer, Cancer, Neurology |
| Therapuetic Areas: | Neurology, Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 12/16/2018 |
| Start Date: | September 18, 2017 |
| End Date: | September 18, 2019 |
| Contact: | Ting Bao, MD |
| Email: | baot@mskcc.org |
| Phone: | 646-888-0865 |
Yoga for Chemotherapy-Induced Peripheral Neuropathy in Breast and GYN Cancer Survivors: A Pilot Study
Some types of chemotherapy used to treat breast cancer can cause damage to nerves with
symptoms like tingling, numbness, muscle weakness, and pain in the hands and feet that can
last and can affect functioning. The purpose of this study is to find out the effects of yoga
on reducing symptoms caused by such nerve damage.
symptoms like tingling, numbness, muscle weakness, and pain in the hands and feet that can
last and can affect functioning. The purpose of this study is to find out the effects of yoga
on reducing symptoms caused by such nerve damage.
Inclusion Criteria:
- English-speaking
- Age >/= 18 years old
- Survivors with a primary diagnosis of stage I-III breast, ovarian uterine, or
endometrial cancer
- Moderate to severe chemotherapy induced peripheral neuropathy, defined by symptoms
such as numbness, tingling, or pain ratings of 4 or greater on a 0-10 numeric rating
scale
- Have completed neurotoxic chemotherapy, i.e. taxanes (paclitaxel, docetaxel) and
platinum (carboplatin) at least 3 months prior to enrollment
- If taking anti-neuropathy medications, they are on a stable regiment (no change in 3
months)
- ECOG performance status 0-2
Exclusion Criteria:
- Participants with metastatic disease
- Participants who are currently receiving physical therapy or practicing yoga for any
reason
Control Group - Inclusion/Exclusion Criteria
Inclusion Criteria:
- English speaking
- Age >/= 18 years old
- Survivors with a primary diagnosis of Stage I-III breast, ovarian, uterine, or
endometrial cancer
- CIPN symptoms such as numbness, tingling, or pain ratings < 2 on a 0-10 NRS scale
- Have completed neurotoxic chemotherapy, i.e. taxanes (paclitaxel, docetaxel) and
platinum (carboplatin) at least 3 months prior to enrollment
- ECOG performance status 0-2
Exclusion Criteria:
- Patients with metastatic disease
- Patients taking anti-neuropathy medication
- Patients who are currently receiving physical therapy or practicing yoga for any
reason
We found this trial at
2
sites
1275 York Ave
New York, New York 10021
New York, New York 10021
(212) 639-2000
Phone: 646-888-0865
Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering Cancer Center — the world's oldest and...
Click here to add this to my saved trials
Click here to add this to my saved trials